Advertisement
Policy Forum

Policy Forum Policy Forum articles provide a platform for health policy makers from around the world to discuss the challenges and opportunities in improving health care to their constituencies.

See all article types »

Clinical Trial Registration: The Differing Views of Industry, the WHO, and the Ottawa Group

  • Karmela Krleža-Jerić
  • Published: October 18, 2005
  • DOI: 10.1371/journal.pmed.0020378

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Beyond Trial Registration: A Global Trial Bank for Clinical Trial Reporting

Ida Sim, Don E Detmer
Health in Action | published 18 Oct 2005 | PLOS Medicine
doi:10.1371/journal.pmed.0020365

Tackling Publication Bias in Clinical Trial Reporting

Emma Veitch
Editorial | published 18 Oct 2005 | PLOS Medicine
doi:10.1371/journal.pmed.0020367

When Clinical Trials Are Compromised: A Perspective from a Patient Advocate

Musa Mayer
Essay | published 18 Oct 2005 | PLOS Medicine
doi:10.1371/journal.pmed.0020358